HeartFlow Analysis vs HealthCCSng
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a comprehensive, non-invasive functional and anatomical assessment of coronary artery disease, particularly when evaluating the hemodynamic significance of stenoses. This tool is ideal for cases where detailed 3D modeling, FFRct analysis, and plaque characterization are needed to guide treatment decisions and personalize patient management.
View HeartFlow Analysis →Choose HealthCCSng if…
Choose HealthCCSng if your primary goal is automated, opportunistic screening and risk stratification for coronary artery disease by quantifying coronary artery calcification from routine, non-cardiac CT scans. This solution is best suited for identifying patients at risk by leveraging existing imaging data to generate a calcium score and categorize CAC without requiring specialized cardiac CT protocols.
View HealthCCSng →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | HealthCCSng |
|---|---|---|
| Pricing | Contact vendor for pricing | Not publicly available |
| Deployment | Cloud-based (AWS) | Cloud-based, integrates with PACS and EMR systems |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HealthCCSngHealthCCSng (Tool B) emphasizes automated analysis of routine CT scans and seamless integration with PACS and EMR systems, suggesting a simpler, more streamlined workflow for a broader user base. HeartFlow Analysis (Tool A), while powerful, involves complex 3D modeling and FFRct analysis, which may require more specialized user interaction and interpretation by cardiologists and radiologists.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis (Tool A) offers a more comprehensive and advanced diagnostic assessment by providing Fractional Flow Reserve derived from CT (FFRct) and detailed plaque characterization, which directly informs revascularization decisions and has extensive clinical validation. While HealthCCSng (Tool B) provides valuable risk stratification through automated coronary artery calcification (CAC) scoring from routine scans, HeartFlow's functional assessment offers a deeper insight into the physiological impact of blockages.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis (Tool A) has a significant advantage due to its established Category I CPT codes for FFRct Analysis (75580) and AI-Enabled Quantitative Plaque Analysis (75577 for 2026), with documented coverage by Medicare and most U.S. commercial payers. HealthCCSng (Tool B) states its pricing is not publicly available, and while it mentions CPT codes 0721T & 0722T for reimbursement, the transparency and breadth of coverage are less clear compared to HeartFlow's established pathways.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and cloud-based. HealthCCSng explicitly states seamless integration with PACS and EMR systems. HeartFlow also integrates with hospital IT systems, including PACS and EMR, to receive CT scans and deliver results, ensuring smooth workflow incorporation and data exchange.
Innovation
HeartFlow AnalysisHeartFlow Analysis (Tool A) stands out for its pioneering work in deriving Fractional Flow Reserve (FFRct) and performing computational fluid dynamics (CFD) for blood flow simulation from standard CT scans, offering a non-invasive functional assessment that was previously invasive. HealthCCSng (Tool B)'s innovation lies primarily in automating and integrating coronary artery calcification (CAC) scoring from routine CT scans, which, while valuable for opportunistic screening, builds upon an established risk assessment method.
Support & Docs
TieBoth companies offer FDA-cleared medical devices, which inherently requires robust support, training, and comprehensive documentation to ensure safe and effective use. HeartFlow explicitly details its comprehensive support, including hands-on training, technology integration, coding support, and educational materials. While HealthCCSng's documentation isn't as detailed in the provided facts or search results, as a commercial-stage medical technology company, it is expected to provide professional customer support and technical resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | HealthCCSng |
|---|---|---|
| Company | HeartFlow | Nano-X AI |
| Tagline | Decisive Coronary Care | Empowering physicians in the assessment of coronary artery calcium from routine CT scans. |
| Primary Diagnostic Focus | Diagnosing and managing coronary artery disease (CAD) | Identifying patients at risk of coronary artery disease by detecting and quantifying coronary artery calcification (CAC) |
| Payer Coverage | Covered by Medicare and most U.S. commercial payers; Category I CPT codes (75580, 75577 for 2026) established. | Not specified |
| Core Analysis Technique | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Computational Fluid Dynamics (CFD) | Automated detection and quantification of coronary artery calcification (CAC) from routine CT scans |
| Key Output/Insight | Personalized 3D models of coronary arteries, FFRct values, Plaque Analysis (quantification and characterization) | Numerical calcium score, categorization into 'zero', 'low', 'moderate', 'severe' CAC, visualization of calcified plaques |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and HealthCCSng.